On the recordFebruary 3, 2016
I do worry that it is important in the case of biosimilars or generics that that continue to be a way of reducing drug pricing.
Source
congress.govI do worry that it is important in the case of biosimilars or generics that that continue to be a way of reducing drug pricing.
Pallone highlights the importance of biosimilars and generics in reducing drug prices.
Share
More from Frank Pallone
What has also become apparent from my examination of data centers is your company’s disregard for the health and well-being of local communities.
This $9.6 million investment helps to put another vessel on the water and takes cars off our overcrowded roads. That is exactly what federal infrastructure dollars should be doing.